Boris Petrikovsky, MD
Maternal & Fetal Medicine · East Meadow, NYNPI 1801863659
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $316 of the $351 with a category attached, or 89.9%. 10 manufacturers reported payments, led by AbbVie at 34.2% of the total.
Across 15 payments — averaging $23.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$120
- Myriad Women's Health, Inc.$62
- Takeda Pharmaceuticals U.S.A., Inc.$27
- Shield Therapeutics Inc$24
- Myovant Sciences Inc.$22
- Hologic Sales And Service, LLC$21
- plus $74 from 4 others
What the payments were for
- Food & beverage$31690%
- Education$3510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $120 |
| Myriad Women's Health, Inc. | 1 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Shield Therapeutics Inc | 1 | $24 |
| Myovant Sciences Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Biogen | 1 | $20 |
| Pfizer | 1 | $19 |
| Millicent US Inc | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$351 in reported general payments places this provider in the 70th percentile of 185 maternal & fetal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 12 | $478 |
| Metronidazole | 18 | $279 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $267 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $176 |
| Fluconazole | 25 | $170 |
Paid to pharmacies, not to this prescriber.
Other maternal & fetal medicine in East Meadow
- Martin ChavezMineola$310K
- Heather LipkindNew York$60K
- Mary DaltonNew York$58K
- Eran BornsteinNew York$56K
- Ilan TimorNew York$36K
- Lisa NathanNew York$32K
- Daniel SkupskiFlushing$17K
- Ellen LandsbergerLarchmont$12K
- Kevin JovanovicNew York$10K
- Russell MillerNew York$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.